Why choose a one-stop MedTech due diligence service instead of individual reports?
When investing in medical devices and in vitro diagnostic devices, standards, classification, and the approval process determine whether a good idea will become a marketable product or an expensive bad investment.
The YOOme Investor Package offers two complementary services for this purpose. The Investment Readiness Check conducts an independent assessment prior to the investment to determine whether a target is technically feasible and regulatory compliant. The Portfolio Accelerator provides support after the investment—including development, regulatory approval, and filling gaps in expertise—to ensure the investment stays on schedule.
Because software, hardware, regulatory affairs, product design, and UX/UI are all handled under one roof, you’ll have a single point of contact instead of dealing with fragmented individual service providers, and you’ll have a decision-making framework that stands up to scrutiny from boards and co-investors.

Investor Package for Investors at Every Stage of a MedTech Investment
A Partner for the Entire Investment Cycle
YOOme guides you through three phases, providing you with a dedicated point of contact instead of a fragmented group of individual service providers.


Package A: Investment Readiness Check for MedTech and IVD
Technical due diligence and risk assessment for medtech, IVD, and digital health opportunities to prevent costly investment mistakes from happening in the first place.
Package A: Investment Readiness Check for MedTech and IVD
Technical due diligence and risk assessment for medtech, IVD, and digital health opportunities to prevent costly investment mistakes from happening in the first place.
Five disciplines, all under one roof
All of the YOOme Group’s services are available to you from a single source, from legal manufacturing to UX/UI design.
What We Review
Four key areas form the core of your medtech due diligence. Together, they answer the question that matters most before any investment decision: Can the product be technically developed, approved, and brought to market within the planned timeframe and budget?
How We Work
Investment Readiness Check Costs: A Fixed Price for Your Due Diligence
OR
* Screening: approximately 2 weeks. Confirmatory testing: 4 to 6 weeks. Third-party costs will be billed separately based on actual expenses.
How You Can Benefit from the Portfolio Accelerator
You bring exactly the expertise your portfolio company needs at the current stage of the project—without lengthy recruiting processes and with flexible scope. At the same time, as an investor, you can keep track of your investment’s progress at all times.
Time horizon: Disciplines run in parallel, not additively
Regulatory issues are rarely the bottleneck. Hardware prototyping and clinical evaluation are usually the time-sensitive steps.

Portfolio Accelerator Costs: Monthly Hour Allowance
* Unused hours can be carried over for 3 months.
Proven in the Market: A Selection of Our MedTech Projects
Proven in the Market: A Selection of Our MedTech Projects
Your YOOme Experts
YOOme consists of the teams at BAYOOCARE (legal manufacturer), BAYOOMED (medical software), Mechatronic Medical Engineers (development & manufacturing), Puls Produktdesign (product design & UX), and UID (user interface design). All YOOme partners are part of the BAYOONET Group, which has 350 employees , and have carried out numerous joint projects, developed medical devices, and brought them to market internationally.
350+
Experts at the BAYOONET Group
5
Academic Disciplines in One Package
50+
Countries for international market approval
ISO 13485
MDSAP-certified, operating throughout the DACH region
350+
Experts at the BAYOONET Group
5
Academic Disciplines in One Package
50+
Countries for international market approval
ISO 13485
MDSAP-certified, operating throughout the DACH region
Frequently Asked Questions About the Investor Package
Any questions?





















